The Uromigos Episode 376: Bladder Cancer 2024 Highlights | GU Oncology Now
Dr. Matt Galsky joins Brian and Tom to discuss the most impactful data in bladder cancer from 2024.
Dr. Matt Galsky joins Brian and Tom to discuss the most impactful data in bladder cancer from 2024.
npj Science of Food – Utilization of plant-based foods for effective prevention of chronic diseases: a longitudinal cohort study
Tom Brokaw explains the relationship between Canada and The United States, in a pre-recorded short film that aired on NBC, prior to the Opening Ceremonies…
The Institutional Review Board (IRB)-approved Pregnancy and Lung Cancer Registry, was launched by the Florez Lab in December 2023 to collect data from around the…
Ellinor Goergen, MD, of the University of Cologne in Germany, discusses her ASH 2024 presentation on quality-of-life outcomes in the phase III CLL12 trial.
Join moderator George A. Mensah, MD, FACC and a leading panelist of experts including Glaucia Maria Moraes de Oliviera, MD, MSc, PhD, FACC, Melvin Echols,…
Department of Medicine, Division of Cardiology, University of California San Francisco, San Francisco, California, USA ∗Address for correspondence: Dr Connor O’Brien, University of California-San Francisco,…
For SOHO, 2024 was a year of firsts and continued growth of the society worldwide. Current SOHO President Phillip Scheinberg, MD, PhD, chief of hematology…
A study examined whether COVID-19 independently affects the subsequent trajectory of kidney function in patients with IgA nephropathy (IgAN).
AbstractBackgroundBreast arterial calcification (BAC) on mammograms has emerged as a biomarker of women’s cardiovascular disease (CVD) risk, but there is a lack of quantification tools…
Key Points. The incidence of primary refractory disease has decreased with modern therapy, but it is a significant risk factor for shorter survival.Salvage auto